Climb Bio Inc (CLYM) stock news · rev $8.1M
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
This CLYM news page leads with what Climb Bio Inc filed — not a scraped headline mill.
No cached 8-K sentence for CLYM yet. We will not pad this page with generic market recap.
Latest reported CLYM revenue for 2024-12-31 was $8.1M. Net income was -$73.9M. Revenue was up 76.0% from 2023-12-31 to 2024-12-31. CLYM currently screens at market cap $85.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CLYM stock page; for the tape open the quote page.
CLYM stock news FAQ
What are CLYM's latest revenue and net income?
Latest cached Climb Bio Inc (CLYM) revenue for Dec 31, 2024 was $8.1M. Net income was -$73.9M. Statements: https://lician.com/financials/clym
How did CLYM revenue change from the prior cached period?
Cached Climb Bio Inc (CLYM) revenue was up 76.0% from $4.6M (Dec 31, 2023) to $8.1M (Dec 31, 2024). Statements: https://lician.com/financials/clym
What is CLYM's market cap?
Climb Bio Inc (CLYM) market cap is $85.8M on the latest cached fundamentals snapshot.
What kind of company is CLYM?
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
Where is CLYM stock news listed?
Cached stock news for Climb Bio Inc (CLYM) is listed at https://lician.com/news/clym. Filings: https://lician.com/sec/clym
Not investment advice.